{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:17:35Z","timestamp":1779333455237,"version":"3.51.4"},"publisher-location":"Totowa, NJ","reference-count":67,"publisher":"Humana Press","isbn-type":[{"value":"9781627030700","type":"print"},{"value":"9781627030717","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-62703-071-7_7","type":"book-chapter","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T19:48:03Z","timestamp":1354304883000},"page":"121-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cytokines as Potential Biomarkers for Parkinson\u2019s Disease: A Multiplex Approach"],"prefix":"10.1007","author":[{"given":"Darcy","family":"Litteljohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Hayley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"issue":"1","key":"7_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00702-011-0682-x","volume":"119","author":"M Gerlach","year":"2012","unstructured":"Gerlach M et al (2012) Biomarker candidates of neurodegeneration in Parkinson\u2019s disease for the evaluation of disease-modifying therapeutics. J Neural Transm 119(1):39\u201352. doi:10.1007\/s00702-011-0682-x","journal-title":"J Neural Transm"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11910-010-0144-0","volume":"10","author":"JC Morgan","year":"2010","unstructured":"Morgan JC, Mehta SH, Sethi KD (2010) Biomarkers in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 10:423\u2013430","journal-title":"Curr Neurol Neurosci Rep"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson\u2019s disease. Lancet Neurol 5:75\u201386","journal-title":"Lancet Neurol"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2217\/bmm.10.93","volume":"4","author":"MG Schlossmacher","year":"2010","unstructured":"Schlossmacher MG, Mollenhauer B (2010) Biomarker research in Parkinson\u2019s disease: objective measures needed for patient stratification in future cause-directed trials. Biomark Med 4:647\u2013650","journal-title":"Biomark Med"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"713517","DOI":"10.4061\/2011\/713517","volume":"2011","author":"D Litteljohn","year":"2010","unstructured":"Litteljohn D et al (2010) Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinsons Dis 2011:713517. doi:10.4061\/2011\/713517","journal-title":"Parkinsons Dis"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.01.004","volume":"85","author":"H Anisman","year":"2008","unstructured":"Anisman H, Merali Z, Hayley S (2008) Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85:1\u201374","journal-title":"Prog Neurobiol"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","volume":"63","author":"SX Leng","year":"2008","unstructured":"Leng SX et al (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63:879\u2013884","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/mds.10387","volume":"18","author":"AF Leentjens","year":"2003","unstructured":"Leentjens AF et al (2003) Higher incidence of depression preceding the onset of Parkinson\u2019s disease: a register study. Mov Disord 18:414\u2013418","journal-title":"Mov Disord"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2006.05.031","volume":"248","author":"E Stefanova","year":"2006","unstructured":"Stefanova E et al (2006) Depression predicts the pattern of cognitive impairment in early Parkinson\u2019s disease. J Neurol Sci 248:131\u2013137","journal-title":"J Neurol Sci"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","volume":"54","author":"WM McDonald","year":"2003","unstructured":"McDonald WM, Richard IH, DeLong MR (2003) Prevalence, etiology, and treatment of depression in Parkinson\u2019s disease. Biol Psychiatry 54:363\u2013375","journal-title":"Biol Psychiatry"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"17087","DOI":"10.1073\/pnas.0704144104","volume":"104","author":"Y Temel","year":"2007","unstructured":"Temel Y (2007) Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci U S A 104:17087\u201317092","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/00207450701239418","volume":"118","author":"PG Frisina","year":"2008","unstructured":"Frisina PG et al (2008) The effects of antidepressants in Parkinson\u2019s disease: a meta-analysis. Int J Neurosci 118:667\u2013682","journal-title":"Int J Neurosci"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000113682","volume":"5","author":"D Berg","year":"2008","unstructured":"Berg D (2008) Biomarkers for the early detection of Parkinson\u2019s and Alzheimer\u2019s disease. Neurodegener Dis 5:133\u2013136","journal-title":"Neurodegener Dis"},{"key":"7_CR14","first-page":"339","volume-title":"Parkinson\u2019s disease","author":"M Trew","year":"2005","unstructured":"Trew M, Suchowersky O (2005) Anxiety and Parkinson\u2019s disease. In: Pfeiffer RF, Ebadi M (eds) Parkinson\u2019s disease. CRC Press, Boca Raton, FL, pp 339\u2013346"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role for cytokines. Curr Pharm Des 11:999\u20131016","journal-title":"Curr Pharm Des"},{"issue":"7","key":"7_CR16","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.neurobiolaging.2011.02.016","volume":"33","author":"EN Mangano","year":"2012","unstructured":"Mangano EN et al (2012) Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging 33(7):1411\u20131426. doi:10.1016\/j.neurobiolaging.2011.02.016","journal-title":"Neurobiol Aging"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2741\/2713","volume":"13","author":"MG Tansey","year":"2008","unstructured":"Tansey MG et al (2008) Neuroinflammation in Parkinson\u2019s disease: is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 13:709\u2013717","journal-title":"Front Biosci"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale M et al (2009) Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun 23:55\u201363","journal-title":"Brain Behav Immun"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","volume":"167","author":"H Chen","year":"2008","unstructured":"Chen H et al (2008) Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. Am J Epidemiol 167:90\u201395","journal-title":"Am J Epidemiol"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","volume":"41","author":"SM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien SM et al (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41:326\u2013331","journal-title":"J Psychiatr Res"},{"issue":"2","key":"7_CR21","doi-asserted-by":"publisher","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","volume":"5","author":"E Domenici","year":"2010","unstructured":"Domenici E et al (2010) Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 5(2):e9166. doi:10.1371\/journal.pone.0009166","journal-title":"PLoS One"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1210\/jc.2004-1667","volume":"90","author":"S Alesci","year":"2005","unstructured":"Alesci S et al (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90:2522\u20132530","journal-title":"J Clin Endocrinol Metab"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jpsychires.2009.05.010","volume":"43","author":"FS Dhabhar","year":"2009","unstructured":"Dhabhar FS et al (2009) Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res 43:962\u2013969","journal-title":"J Psychiatr Res"},{"issue":"12","key":"7_CR24","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, Dellagioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36(12):2452\u20132459. doi:10.1038\/npp. 2011.132","journal-title":"Neuropsychopharmacology"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.euroneuro.2005.11.011","volume":"16","author":"M Diamond","year":"2006","unstructured":"Diamond M, Kelly JP, Connor TJ (2006) Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol 16:481\u2013490","journal-title":"Eur Neuropsychopharmacol"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4088\/JCP.v66n0106","volume":"66","author":"CL Raison","year":"2005","unstructured":"Raison CL et al (2005) Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 66:41\u201348","journal-title":"J Clin Psychiatry"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/sj.npp.1301137","volume":"31","author":"N Kaneko","year":"2006","unstructured":"Kaneko N et al (2006) Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31:2619\u20132626","journal-title":"Neuropsychopharmacology"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WNR.0b013e328010231a","volume":"18","author":"J Ishikawa","year":"2007","unstructured":"Ishikawa J, Ishikawa A, Nakamura S (2007) Interferon-alpha reduces the density of monoaminergic axons in the rat brain. Neuroreport 18:137\u2013140","journal-title":"Neuroreport"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2007.02.008","volume":"186","author":"H Anisman","year":"2007","unstructured":"Anisman H et al (2007) Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J Neuroimmunol 186:45\u201353","journal-title":"J Neuroimmunol"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbi.2009.12.001","volume":"24","author":"D Litteljohn","year":"2010","unstructured":"Litteljohn D et al (2010) Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: implications for psychological pathology. Brain Behav Immun 24:462\u2013473","journal-title":"Brain Behav Immun"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1586\/14737159.7.1.87","volume":"7","author":"MM Ling","year":"2007","unstructured":"Ling MM, Ricks C, Lea P (2007) Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev Mol Diagn 7:87\u201398","journal-title":"Expert Rev Mol Diagn"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-59745-447-6_4","volume":"511","author":"HA Young","year":"2009","unstructured":"Young HA (2009) Cytokine multiplex analysis. Methods Mol Biol 511:85\u2013105","journal-title":"Methods Mol Biol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nbd.2008.09.004","volume":"35","author":"M Shi","year":"2009","unstructured":"Shi M, Caudle WM, Zhang J (2009) Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Dis 35:157\u2013164","journal-title":"Neurobiol Dis"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1373\/clinchem.2009.127514","volume":"56","author":"AA Ellington","year":"2010","unstructured":"Ellington AA et al (2010) Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem 56:186\u2013193","journal-title":"Clin Chem"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd817","volume":"1","author":"K Braeckmans","year":"2002","unstructured":"Braeckmans K et al (2002) Encoding microcarriers: present and future technologies. Nat Rev Drug Discov 1:447\u2013456","journal-title":"Nat Rev Drug Discov"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.neurobiolaging.2007.11.020","volume":"30","author":"EN Mangano","year":"2009","unstructured":"Mangano EN, Hayley S (2009) Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration. Neurobiol Aging 30:1361\u20131378","journal-title":"Neurobiol Aging"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbi.2010.11.008","volume":"25","author":"J Gibb","year":"2011","unstructured":"Gibb J et al (2011) Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain Behav Immun 25:468\u2013482","journal-title":"Brain Behav Immun"},{"key":"7_CR38","unstructured":"Luminex Corp (2010) Overcoming the cost and performance limitations of ELISA with xMAP technology. xMAP technology technical note [white paper]. http:\/\/www.luminexcorp.com\/prod\/groups\/public\/documents\/lmnxcorp\/308-xmap-vs.-elisa-white-paper.pdf"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1039\/b807855f","volume":"8","author":"RS Sista","year":"2008","unstructured":"Sista RS et al (2008) Heterogeneous immunoassays using magnetic beads on a digital microfluidic platform. Lab Chip 8:2188\u20132196","journal-title":"Lab Chip"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00216-008-2379-z","volume":"393","author":"M Hartmann","year":"2009","unstructured":"Hartmann M et al (2009) Protein microarrays for diagnostic assays. Anal Bioanal Chem 393:1407\u20131416","journal-title":"Anal Bioanal Chem"},{"key":"7_CR41","unstructured":"Luminex Corp (2010) Equivalent analytical performance between the new MAGPIX system and the Luminex 100\/200 system. xMAP technology technical note [white paper). http:\/\/www.luminexcorp.com\/prod\/groups\/public\/documents\/lmnxcorp\/314-magpix-vs-lx200-white-pape.pdf"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1586\/erv.10.110","volume":"9","author":"GE Lash","year":"2010","unstructured":"Lash GE, Pinto LA (2010) Multiplex cytokine analysis technologies. Expert Rev Vaccines 9:1231\u20131237","journal-title":"Expert Rev Vaccines"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/9780470583128","volume-title":"Assay development: fundamentals and practices","author":"G Wu","year":"2010","unstructured":"Wu G (2010) Assay development: fundamentals and practices. Wiley, Hoboken, NJ, pp 43\u201353"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1021\/ac702628q","volume":"80","author":"RN Fichorova","year":"2008","unstructured":"Fichorova RN et al (2008) Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 80:4741\u20134751","journal-title":"Anal Chem"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1586\/erm.10.3","volume":"10","author":"M Vistnes","year":"2010","unstructured":"Vistnes M, Christensen G, Omland T (2010) Multiple cytokine biomarkers in heart failure. Expert Rev Mol Diagn 10:147\u2013157","journal-title":"Expert Rev Mol Diagn"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jri.2005.03.005","volume":"66","author":"NC Dupont","year":"2005","unstructured":"Dupont NC et al (2005) Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66:175\u2013191","journal-title":"J Reprod Immunol"},{"issue":"7","key":"7_CR47","doi-asserted-by":"publisher","first-page":"e2535","DOI":"10.1371\/journal.pone.0002535","volume":"3","author":"JF Djoba Siawaya","year":"2008","unstructured":"Djoba Siawaya JF et al (2008) An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS One 3(7):e2535. doi:10.1371\/journal.pone.0002535","journal-title":"PLoS One"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2172-10-52","volume":"10","author":"W de Jager","year":"2009","unstructured":"de Jager W et al (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10:52. doi:10.1186\/1471-2172-10-52","journal-title":"BMC Immunol"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","volume":"38","author":"MF Elshal","year":"2006","unstructured":"Elshal MF, McCoy JP (2006) Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38:317\u2013323","journal-title":"Methods"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jim.2009.09.001","volume":"350","author":"L Dossus","year":"2009","unstructured":"Dossus L et al (2009) Validity of multiplex-based assays for cytokine measurements in serum and plasma from \u201cnon-diseased\u201d subjects: comparison with ELISA. J Immunol Methods 350:125\u2013132","journal-title":"J Immunol Methods"},{"key":"7_CR51","first-page":"13","volume":"69","author":"E Codorean","year":"2010","unstructured":"Codorean E et al (2010) Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro. Roum Arch Microbiol Immunol 69:13\u201319","journal-title":"Roum Arch Microbiol Immunol"},{"issue":"1\u20132","key":"7_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jim.2011.06.033","volume":"372","author":"D Dabitao","year":"2011","unstructured":"Dabitao D et al (2011) Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array. J Immunol Methods 372(1\u20132):71\u201377. doi:10.1016\/j.jim.2011.06.033","journal-title":"J Immunol Methods"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1373\/clinchem.2009.135087","volume":"56","author":"Q Fu","year":"2010","unstructured":"Fu Q, Zhu J, Van Eyk JE (2010) Comparison of multiplex immunoassay platforms. Clin Chem 56:314\u2013318","journal-title":"Clin Chem"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","volume":"340","author":"F Chowdhury","year":"2009","unstructured":"Chowdhury F, Williams A, Johnson P (2009) Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 340:55\u201364","journal-title":"J Immunol Methods"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-4682-4-31","volume":"4","author":"BP Hanley","year":"2007","unstructured":"Hanley BP, Xing L, Cheng RH (2007) Variance in multiplex suspension array assays: microsphere size variation impact. Theor Biol Med Model 4:31. doi:10.1186\/1742-4682-4-31","journal-title":"Theor Biol Med Model"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1128\/CVI.05032-11","volume":"18","author":"EC Breen","year":"2011","unstructured":"Breen EC et al (2011) Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 18:1229\u20131242","journal-title":"Clin Vaccine Immunol"},{"key":"7_CR57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4137\/BMI.S660","volume":"3","author":"A Nechansky","year":"2008","unstructured":"Nechansky A et al (2008) Comparison of the calibration standards of three commercially available multiplex kits for human cytokine measurement to WHO standards reveals striking differences. Biomark Insights 3:227\u2013235","journal-title":"Biomark Insights"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jim.2004.04.018","volume":"291","author":"U Prabhakar","year":"2004","unstructured":"Prabhakar U et al (2004) Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1\/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J Immunol Methods 291:27\u201338","journal-title":"J Immunol Methods"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.drudis.2006.09.010","volume":"11","author":"SR Master","year":"2006","unstructured":"Master SR, Bierl C, Kricka LJ (2006) Diagnostic challenges for multiplexed protein microarrays. Drug Discov Today 11:1007\u20131011","journal-title":"Drug Discov Today"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B et al (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230\u2013240","journal-title":"Lancet Neurol"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.nurt.2008.02.003","volume":"5","author":"AL Peterson","year":"2008","unstructured":"Peterson AL, Nutt JG (2008) Treatment of Parkinson\u2019s disease with trophic factors. Neurotherapeutics 5:270\u2013280","journal-title":"Neurotherapeutics"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1586\/ern.10.55","volume":"10","author":"T Yasuda","year":"2010","unstructured":"Yasuda T, Mochizuki H (2010) Use of growth factors for the treatment of Parkinson\u2019s disease. Expert Rev Neurother 10:915\u2013924","journal-title":"Expert Rev Neurother"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1096\/fj.07-095398","volume":"22","author":"NP Visanji","year":"2008","unstructured":"Visanji NP et al (2008) PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson\u2019s disease. FASEB J 22:2488\u20132497","journal-title":"FASEB J"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/ajg.2010.159","volume":"105","author":"P Scully","year":"2010","unstructured":"Scully P et al (2010) Plasma cytokine profiles in females with irritable Bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 105:2235\u20132243","journal-title":"Am J Gastroenterol"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","volume":"7","author":"L Ohman","year":"2010","unstructured":"Ohman L, Simr\u00e9n M (2010) Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 7:163\u2013173","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11920-004-0066-0","volume":"6","author":"DG Folks","year":"2004","unstructured":"Folks DG (2004) The interface of psychiatry and irritable Bowel syndrome. Curr Psychiatry Rep 6:210\u2013215","journal-title":"Curr Psychiatry Rep"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrneurol.2009.135","volume":"5","author":"M Eller","year":"2009","unstructured":"Eller M, Williams DR (2009) Biological fluid biomarkers in neurodegenerative parkinsonism. Nat Rev Neurol 5:561\u2013570","journal-title":"Nat Rev Neurol"}],"container-title":["Methods in Molecular Biology","Psychoneuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-071-7_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T05:11:08Z","timestamp":1676783468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-071-7_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781627030700","9781627030717"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-071-7_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"24 July 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}